Table 1.
Patients’ smoking habit | Cancer stages | ||
---|---|---|---|
Comparison | P‐value | Comparison | P‐value |
Normal vs. non‐smoker | <0.05 | Normal vs. stage 1 | <0.05 |
Normal vs. smoker | <0.05 | Normal vs. stage 2 | <0.05 |
Normal vs. reformed smoker 1 | <0.05 | Normal vs. stage 3 | <0.05 |
Normal vs. reformed smoker 2 | <0.05 | Normal vs. stage 4 | <0.05 |
Non‐smoker vs. smoker | >0.05 | Stage 1 vs. stage 2 | >0.05 |
Non‐smoker vs. reformed smoker 1 | >0.05 | Stage 1‐ vs. stage 3 | >0.05 |
Non‐smoker vs. reformed smoker 2 | >0.05 | Stage 1 vs. stage 4 | >0.05 |
Smoker vs. reformed smoker 1 | >0.05 | Stage 2 vs. stage 3 | >0.05 |
Smoker vs. reformed smoker 2 | >0.05 | Stage 2 vs. stage 4 | >0.05 |
Reformed smoker 1 vs. reformed smoker 2 | >0.05 | Stage 3 vs. stage 4 | >0.05 |
Patients’ gender | |||
---|---|---|---|
Comparison | P‐value | Comparison | P‐value |
Normal vs. male | <0.05 | ||
Normal vs. female | <0.05 | ||
Male vs. female | >0.05 |
Patients’ age | Nodal metastasis status | ||
---|---|---|---|
Comparison | P‐value | Comparison | P‐value |
Normal vs. age (21–40 years) | >0.05 | Normal vs. N0 | <0.05 |
Normal vs. age (41–60 years) | <0.05 | Normal vs. N1 | <0.05 |
Normal vs. age (61–80 years) | <0.05 | Normal vs. N2 | <0.05 |
Normal vs. age (81–100 years) | <0.05 | Normal vs. N3 | >0.05 |
Age (21–40 years) vs. age (41–60 years) | >0.05 | N0 vs. N1 | >0.05 |
Age (21–40 years) vs. age (61–80 years) | >0.05 | N0 vs. N2 | >0.05 |
Age (21–40 years) vs. age (81–100 years) | >0.05 | N0 vs. N3 | >0.05 |
Age (41–60 years) vs. age (61–80 years) | >0.05 | N1 vs. N2 | <0.05 |
Age (41–60 years) vs. age (81–100 years) | >0.05 | N1 vs. N3 | >0.05 |
Age (61–80 years) vs. age (81–100 years) | >0.05 | N2 vs. N3 | >0.05 |
N0, no regional lymph node metastasis; N1, metastases in 1 to 3 axillary lymph nodes; N2, metastases in 4 to 9 axillary lymph nodes; N3, metastases in 10 or more axillary lymph nodes.